WARSAW — Zimmer Biomet Holdings Inc., a global leader in musculoskeletal healthcare, and Medtech SA, a leading French medical technology company, announced that, following the unanimous approval of both companies’ boards of directors, a wholly owned subsidiary of Zimmer Biomet has acquired 1,406,151 Medtech shares, representing 58.77 percent of the outstanding share capital of Medtech, …read more.

WARSAW — Zimmer Biomet Holdings Inc. announced today, Tuesday, June 14, the pricing of the previously announced underwritten secondary offering of 11,116,533 shares of its common stock by certain of its stockholders, consisting of affiliates of KKR, Goldman Sachs and TPG. The shares are being sold to the public at an initial price of $115.85 per …read more.

WARSAW — Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare, announced it will participate in the Goldman Sachs 2015 European Medtech and Healthcare Conference at the Goldman Sachs offices, London, Thursday, Sept. 10. About The Company Founded in 1927 and headquartered in Warsaw, Zimmer Biomet is a global leader in musculoskeletal healthcare that designs, …read more.